About Apicore
Apicore is a Healthcare company based in Somerset (United States) founded in 2004, and was acquired by Medicure in July 2017. APIs are manufactured and custom synthesis services are provided. Apicore has raised $720.12 thousand across 2 funding rounds from investors including Medicure, Knight Therapeutics and Signet Healthcare Partners. The company has 471 employees. Its Indian entity Apicore Pharmaceuticals Private Limited reported revenue of ₹195 Cr. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and API Production.
Company details
Apicore was founded in 2004 in Somerset, United States, within the pharmaceutical chemicals sector. Active pharmaceutical ingredients (APIs) are produced, alongside custom synthesis for early-phase research. A portfolio of 100 API products is maintained, with synthesis capabilities encompassing carbohydrates, nucleosides, prostaglandins, diagnostic agents, liquid APIs, potent compounds, peptides, and complex small molecules. Operations extend to 16 countries globally.
- Headquarters Somerset, United States
- Employees 471
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Website apicore.com
- Social LinkedIn
- Acquired by Medicure (Jul 2017)
- Legal Name Apicore Pharmaceuticals Private Limited
- Date of Incorporation 27 Jul, 2006
- Jurisdiction Vadodara, Gujarat, India
- Indian entity revenue₹195 Cr
FY 2024 · +54% YoY
- Indian entity net profit₹6.98 Cr
FY 2024 · 4% margin
- Indian entity EBITDA₹26.75 Cr
FY 2024 · 14% margin
- Total Equity Funding$720.12K (USD)
in 2 rounds
- Latest Funding Round$720.12K (USD), Series A
Oct 2016
- InvestorsMedicure
& 2 more
- Employee Count471
- Acquired byMedicure
(Jul 2017)
Associated legal entities of Apicore
Apicore operates through Apicore Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Apicore Pharmaceuticals Private Limited CIN U24119GJ2006FTC048777 | Active | 27 Jul 2006 | Padra, Gujarat | ₹195 Cr | 471 | 6 | View details |
Funding Insights of Apicore
Apicore has successfully raised a total of $720.12K across 2 strategic funding rounds. The most recent funding activity was a Series A round of $720.12 thousand completed in October 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $720,118
- Total Rounds 2
- Last Round Series A — $720,118
- Investors Count 3
All 2 funding rounds of Apicore with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2016 | $720,118 | Series A | – | – | – |
| Jul 2014 | Series A | – | – |
3 investors in total: 3 institutional.
Investors in Apicore
Apicore has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Medicure, Knight Therapeutics and Signet Healthcare Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
PE firm investing in North America and Europe | signethealthcarepartners.com | New York, United States | ||
Affordable therapeutics are developed and e-commerce pharmacy services are provided. | 1997 | medicure.com | Winnipeg, Canada | |
Prescription pharmaceuticals are acquired, licensed, and commercialized by the company. | 2014 | gud-knight.com | Westmount, Canada |
Investor details for Apicore
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Apicore Pharmaceuticals Private Limited (Apicore)
Apicore Pharmaceuticals Private Limited is the primary company behind Apicore. The board of Apicore Pharmaceuticals Private Limited currently have 5 directors; the longest-serving is Ravishanker Kovi, appointed in 2006. 9 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ravishanker Kovi DIN 00278107 | Director | 27 Jul 2006 | 20 yrs 3 mo | Apicore Pharmaceuticals Private Limited |
| Jayaraman Kannappan DIN 07016114 | Whole-time director | 19 Nov 2014 | 11 yrs 11 mo | Apicore Pharmaceuticals Private Limited |
| Parthiv Patel DIN 07876985 | Director | 21 May 2018 | 8 yrs 5 mo | Apicore Pharmaceuticals Private Limited |
| Murali Krishna Madala DIN 00928526 | Managing Director | 21 May 2018 | 8 yrs 5 mo | Apicore Pharmaceuticals Private Limited |
| Mahesh Suresh Javale DIN 10390685 | Nominee Director | 12 Nov 2023 | 3 yrs | Apicore Pharmaceuticals Private Limited |
Financials of Apicore
Figures of Apicore Pharmaceuticals Private Limited, the primary company behind Apicore, for FY 2024. Revenue was ₹195 Cr (+54% year on year). Net profit was ₹6.98 Cr (4% margin). EBITDA was ₹26.75 Cr (14% margin). Revenue has grown at a compounded annual rate of +44% over three years and +18% over five years.
- ₹195 CrRevenue · FY 2024 · +54% YoY
- ₹6.98 CrNet profit · 4% margin
- ₹26.75 CrEBITDA · 14% margin
- ₹50.12 CrPaid-up capital
- 471Employees (provident fund records)
- +44%Revenue CAGR, 3 years
- +18%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Apicore Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Apicore
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Apicore
4 dated milestones of Apicore across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Apicore is founded.
- Funding First funding round.
- Funding Latest funding round, Series A, of $720K.
- Exit Acquired by Medicure.
Web traffic of Apicore
Websites that share an audience with Apicore (apicore.com).
- Unique visitors1.3K
per month
- Global rank#5,314,115
among all websites
- Category rank#6,005
Health · Biotechnology and Pharmaceuticals
- Bounce rate38%
- Pages per visit1.8
- Average visit39 sec
- DevicesDesktop 32% · Mobile 68%
Websites whose visitors overlap most with Apicore. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
abbottcontractmfg.com | abbottcontractmfg.com | 100% | – | ||
| zclchemicals.com | 99% | View details | |||
| ropack.com | 99% | #8,296,511 | View details | ||
| neostx.com | 98% | View details | |||
| akorn.com | 98% | #11,843,991 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for Apicore
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Apicore (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Apicore
Complete news archive for Apicore
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Apicore
Apicore was founded in 2004 and raised its 1st funding round 10 years after it was founded.
Apicore is headquartered in Somerset, United States.
Apicore is a funded company, having raised a total of $720.12K across 2 funding rounds to date.
Apicore has 471 employees.
The primary company behind Apicore, Apicore Pharmaceuticals Private Limited, reported revenue of ₹195 Cr for FY 2024, up 54% year on year.
Apicore was founded in 2004 in Somerset, United States, within the pharmaceutical chemicals sector. Active pharmaceutical ingredients (APIs) are produced, alongside custom synthesis for early-phase research. A portfolio of 100 API products is maintained, with synthesis capabilities encompassing carbohydrates, nucleosides, prostaglandins, diagnostic agents, liquid APIs, potent compounds, peptides, and complex small molecules. Operations extend to 16 countries globally.
Apicore has 3 investors. Key investors include Medicure, Knight Therapeutics, and Signet Healthcare Partners.
Apicore operates through Apicore Pharmaceuticals Private Limited.
Yes. Apicore was acquired by Medicure in July 2017.
The legal entities of Apicore currently have 6 directors, including Ravishanker Kovi, Parthiv Patel, Anjali Hemant Prasad and others.